Which statement indicates the patient needs further instruction about drug therapy after a kidney transplant?

The statement indicating that the patient requires further instruction about drug therapy after a kidney transplant is one that incorrectly suggests a possibility of discontinuing a critical immunosuppressive medication, in this case, cyclosporine. After a kidney transplant, patients are typically placed on a regimen of immunosuppressive drugs to prevent the body from rejecting the new organ. Cyclosporine is a cornerstone of these regimens and is often required indefinitely to maintain graft function, especially in the early years following transplant when the risk of rejection is heightened.

Over time, while the dose may be adjusted and, in some cases, other immunosuppressants may be introduced or emphasized, completely discontinuing cyclosporine is generally not considered safe or advisable without medical supervision. This is because even years out from transplant, the risk of rejection and the need for ongoing immunosuppression can persist. Therefore, this patient's belief about stopping cyclosporine after a couple of years shows a misunderstanding of the importance of ongoing immunosuppression, indicating the need for further education regarding their medication regimen and the management of their transplant.

The other statements reflect a better understanding of the requirements and risks associated with post-transplant care. For instance, the necessity of intravenous medications during